Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach.
Miyssa I AbdelmageedAbdelrahman Hamza Abdelmoneim HamzaMujahed I MustafaNafisa M ElfadolNaseem S MurshedShaza W ShantierAbdelrafie M MakhawiPublished in: BioMed research international (2020)
The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target. Nevertheless, the proposed vaccine rapidly needs to be validated clinically in order to ensure its safety and immunogenic profile to help stop this epidemic before it leads to devastating global outbreaks.